|
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort
|
Aug 2020
|
Pediatric Blood & Cancer
|
aplastic anemia, pediatric
|
|
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium
|
Aug 2020
|
Pediatric Blood & Cancer
|
aplastic anemia, myelodysplastic syndromes (MDS), pediatric
|
|
Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia
|
May 2012
|
Pediatrics
|
aplastic anemia
|
|
Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study
|
Jul 2014
|
PLoS One
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
|
Mar 2017
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria.
|
Sep 2020
|
PloS One
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia
|
Mar 2014
|
PLoS One
|
aplastic anemia
|
|
Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis
|
Feb 2017
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis
|
Nov 2016
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes
|
Jan 2012
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
